Komori
Kidswell Bio (4584) · RiskRestated

Risks Related to Patent Grant, Technological Obsolescence, and Third-Party Infringement

First written in FY2016. 11 of 12 entries say "Restated". Latest entry: FY2023-Q3.

12entries
8years
0from disclosures
Share on X
How it moved
ProgressHeldSoftenedWorseRestatedFY2016 – FY2023-Q32016: 320162017: 320172018: 320182019: 120192020: 120202021: 020212022: 020222023: 1
Same theme, other companies

The whole theme swung hardest in 2020: 4 of 43 companies on the "Worse" side.

64 other companies' latest entry also says "Restated".

Ridges = years it wrote progress, valleys = years it wrote worse. Most hopeful companies at the back. Drag to turn, scroll to zoom, right-drag to pan. On a phone, two fingers turn and pinch to zoom; one finger scrolls the page.
Showing 14 of the 108 companies compared. The sentences above are computed from all 108.
Full recordFilings, disclosures and news, newest first
  1. FY2023-Q3RestatedAnnual report

    「During the cumulative third-quarter period, there were no new business risks and no material changes in the business risks described in the annual securities report for the preceding fiscal year.」

    The company disclosed that there had been no material change in the risks relating to patent grants, technological obsolescence and third-party infringement.
  2. FY2020RestatedAnnual report

    「However, there is no assurance that all of the patents and other rights for which the company has filed applications will be granted. Even if such patents and other rights are granted, the technologies covered by them could become obsolete as superior technologies that surpass them emerge」

    The company continues to disclose the risks of failure to obtain patents, technological obsolescence and infringement of third-party intellectual property rights.
  3. FY2019RestatedAnnual report

    「However, there is no assurance that all of the patents and other rights for which the company has filed applications will be granted. Even if such patents and other rights are granted, the technologies covered by them could become obsolete as superior technologies that surpass them emerge」

    The company continues to disclose the risks of failure to obtain patents, technological obsolescence and infringement of third-party intellectual property rights.
  4. FY2019-Q1RestatedAnnual report

    「During the cumulative first-quarter period, there were no new business or other risks and no material changes to the business or other risks described in the annual securities report for the previous fiscal year.」

    The company disclosed that there had been no material change in the risks relating to patent grants, technological obsolescence and third-party infringement.
  5. FY2018RestatedAnnual report

    「However, there is no assurance that all of the patents and other rights for which the company has filed applications will be granted. Even if such patents and other rights are granted, the technologies covered by them could become obsolete as superior technologies that surpass them emerge」

    The company continues to disclose the risks of failure to obtain patents, technological obsolescence and infringement of third-party intellectual property rights.
  6. FY2018-Q3RestatedAnnual report

    「During the nine months ended September, there were no new business or other risks, nor any material changes to the business or other risks described in the securities report for the prior fiscal year.」

    The company disclosed that there had been no material change in the risks relating to patent grants, technological obsolescence and third-party infringement.
  7. FY2018-Q2RestatedAnnual report

    「During the six months ended June, there were no new business or other risks, nor any material changes to the business or other risks described in the securities report for the prior fiscal year.」

    The company disclosed that there had been no material change in the risks relating to patent grants, technological obsolescence and third-party infringement.
  8. FY2017RestatedAnnual report

    「However, there is no assurance that all of the patents and other rights for which the company has filed applications will be granted. Even if such patents and other rights are granted, the technologies covered by them could become obsolete as superior technologies that surpass them emerge」

    The company continues to disclose the risks of failure to obtain patents, technological obsolescence and infringement of third-party intellectual property rights.
  9. FY2017-Q3RestatedAnnual report

    「During the nine months ended September, there were no new business or other risks, nor any material changes to the business or other risks described in the securities report for the prior fiscal year.」

    The company disclosed that there had been no material change in the risks relating to patent grants, technological obsolescence and third-party infringement.
  10. FY2017-Q2RestatedAnnual report

    「During the six months ended June, there were no new business or other risks, nor any material changes to the business or other risks described in the securities report for the prior fiscal year.」

    The company disclosed that there had been no new occurrence or material change in the risks relating to patent grants, technological obsolescence and third-party infringement.
  11. FY2017-Q1RestatedAnnual report

    「During the three months ended March, there were no new business or other risks, nor any material changes to the business or other risks described in the securities report for the prior fiscal year.」

    The company disclosed that there had been no material change in the risks relating to patent grants, technological obsolescence and third-party infringement.
  12. FY2016First statedAnnual report

    「There is no assurance that all of the patents and other rights for which the company has filed applications will be granted. Even if such patents and other rights are granted, the technologies covered by them could become obsolete as superior technologies that surpass them emerge」

    The company identifies the failure to obtain its own patents, technological obsolescence, infringement of third-party patents and termination of licences as intellectual property risks.
Moved together

None of this company's other threads moved the same way in the same document twice or more.

When this could move next
No upcoming earnings preview for Kidswell Bio yet.
News
No news is linked to this thread yet. When an article touches it, it will appear here by date.
Risks Related to Patent Grant, Technological Obsolescence, and Third-Party Infringement | Kidswell Bio Corporation (4584) | Komori